BCM
SONM icon

Bridgeway Capital Management’s DNA X Inc SONM Stock Holding History

Bridgeway Capital Management’s Portfolio SONM Stock Details SONM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-24
Closed -$36K – 1393
2021
Q1 		$36K Sell
24
-84
-78% -$148K ﹤0.01% 1349
2020
Q4 		$140K Sell
108
-51
-32% -$55.7K ﹤0.01% 1245
2020
Q3 		$222K Buy
159
+70
+79% +$113K 0.01% 1158
2020
Q2 		$130K Buy
89
+36
+68% +$57.5K ﹤0.01% 1213
2020
Q1 		$67K Hold
53
– – ﹤0.01% 1210
2019
Q4 		$347K Buy
+53
New +$261K ﹤0.01% 1087

Other funds holding SONM

BRF
B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DAS
Dynamic Advisor Solutions Phoenix, Arizona $3.53B AUM 22.61% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bridgeway Capital Management's SONM Position: Q2 2021 in Review

Bridgeway Capital Management sold out of DNA X Inc (SONM) in Q2 2021, closing a stake of 24 shares — an estimated $36K sold.

Bridgeway Capital Management first reported a position in SONM in Q4 2019 and held it in 6 quarters. The position peaked at $347K in Q4 2019. 17 funds tracked by Wall St. Rank hold SONM as of Q2 2021.

  • Bridgeway Capital Management reported no remaining DNA X Inc position as of Q2 2021 after selling out during the quarter.
  • Bridgeway Capital Management sold 24 DNA X Inc shares in Q2 2021, an estimated $36K.
  • Bridgeway Capital Management first reported a position in DNA X Inc in Q4 2019 and held it in 6 quarters.
  • Bridgeway Capital Management's DNA X Inc position peaked at $347K in Q4 2019.
  • 17 funds tracked by Wall St. Rank held DNA X Inc as of Q2 2021.

Based on Bridgeway Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.